English
Spanish
Blog
Vancomycin, Trough Level
Test code: L314 Methodology: Immunoassay Specimen Required: Collect: Red Top Tube – 0.5 ml seerum. Specimen Preparation: Serum free from hemolysis is the recommended specimens. Separate serum or plasma from cells ASAP or within 2 hours of...
Read More ›
Cancer HOTSPOT Panel (50 genes)-(Next Generation Sequencing (NGS))
Currently approved only for NJ NGS is indicated for solid tumors in early stage disease where genetic profile from multiple genes informs diagnosis or disease stratification, prognosis, or treatment options. For late stage cancers, NGS can be used...
Read More ›
UROVYSION for Bladder Cancer – (Fluorescence in-situ Hybridization (FISH))
Approved for NJ and NY UROVYSION – Urovysion™ is a sensitive and specific test used to diagnose urothelial carcinoma in urine. UroVysion has been approved by the FDA for both monitoring of patients with a history of bladder cancer and detection...
Read More ›
ONCOLOGY: Hematological Malignancies
Chronic Myeloid Leukemia (RT-PCR) – Currently approved only for NJ BCR-ABL assay is an in vitro nucleic acid amplification test for the quantitation of BCR-ABL1 and ABL1 transcripts in total RNA from whole blood of diagnosed t(9;22) positive...
Read More ›
HEREDITARY (GENETIC) SCREENING
Hemachromatosis (HFE Gene Testing) – Currently approved only for NJ HFE Hemochromatosis gene (HFE) testing is a blood test used to check for hereditary hemochromatosis, an inherited disorder that causes the body to absorb too much iron. The iron...
Read More ›
Fragile X (FXS Gene Testing)
Currently approved only for NJ Fragile X is a triplet CGG repeat primed PCR assay followed by fragment size analysis by capillary electrophoresis (CE). Methylation analysis is used to distinguish between premutation and full mutation alleles....
Read More ›